Randomized phase II trial of Carboplatin/Gemcitabine versus Cisplatin/Gemcitabine for the patient with completely resected pathological stage IB-IIIA of Non Small Cell Lung Cancer
Phase 2
- Conditions
- on Small Cell Lung Cancer
- Registration Number
- JPRN-UMIN000000913
- Lead Sponsor
- Hokkaido Lung Cancer Clinical Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 102
Inclusion Criteria
Not provided
Exclusion Criteria
1. sever infection 2. uncontrolled Diabetes Mellitus and hypertension, unstable angina or Myocardial Infarction within 6 months 3. apparent interstitial pneumonitis at chest rentogenogram 4. Uncontrollable pleural effusion 5. multiple lung cancer or other-type cancer within 5 years 6. History of severe hypersensitivity 7. Pregnant or expecting woman
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method